Apokyn

Apokyn is a brand name of apomorphine, approved by the FDA in the following formulation(s):

APOKYN (apomorphine hydrochloride - injectable; subcutaneous)

• 
  Manufacturer: US WORLDMEDS
  
  Approval date: April 20, 2004
  
  Strength(s): 30MG/3ML (10MG/ML) ^[RLD]

Has a generic version of Apokyn been approved?

No. There is currently no therapeutically equivalent version of Apokyn available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Apokyn. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Apokyn.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • April 20, 2011 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Apokyn Consumer Information (Drugs.com)
• Apokyn Consumer Information (Wolters Kluwer)
• Apokyn Consumer Information (Cerner Multum)
• Apokyn Advanced Consumer Information (Micromedex)
• Apokyn AHFS DI Monographs (ASHP)
• Apomorphine Consumer Information (Wolters Kluwer)
• Apomorphine Consumer Information (Cerner Multum)
• Apomorphine Subcutaneous Advanced Consumer Information (Micromedex)
• Apomorphine Hydrochloride AHFS DI Monographs (ASHP)

Docflecai

Docflecai may be available in the countries listed below.

Ingredient matches for Docflecai

Flecainide

Flecainide acetate (a derivative of Flecainide) is reported as an ingredient of Docflecai in the following countries:

• Belgium

International Drug Name Search

Rosiden

Rosiden may be available in the countries listed below.

Ingredient matches for Rosiden

Piroxicam

Piroxicam is reported as an ingredient of Rosiden in the following countries:

• Singapore

International Drug Name Search

Nikoran

Nikoran may be available in the countries listed below.

Ingredient matches for Nikoran

Nicorandil

Nicorandil is reported as an ingredient of Nikoran in the following countries:

• Myanmar


• Vietnam

International Drug Name Search

Simaldrate

Scheme

Prop.INN

CAS registry number (Chemical Abstracts Service)

0012408-47-8

Chemical Formula

Al2-Mg2-O11-Si3·(H2O)n

Therapeutic Category

Antacid

Chemical Names

Aluminate(4-), tris[metasilicato(2-)]dioxodi-, magnesium (1:2), hydrate

Aluminosilicic acid (H₄Al₂Si₃O₁₁), magnesium salt (1:2), hydrate

Magnesium Aluminosilicate hydrate (WHO)

Foreign Names

• Simaldratum (Latin)
• Simaldrat (German)
• Simaldrate (French)
• Simaldrato (Spanish)

Generic Names

• Magnesium Aluminometasilicate (OS: JAN)
• Silodrate (OS: USAN)
• Dimagnesiumaluminiumtrisilicat (IS)
• MP 1051 (IS: Mallinckrodt)
• Simaldolate (IS)
• Magnesium Aluminometasilicate (PH: NF 27)

Brand Names

• Cabagin U (Simaldrate and Methionine, L-)
  Kowa Souyaku, Japan



• Gelusil
  Hemofarm, Georgia; Hemofarm, Serbia; Hemofarm, Russian Federation; Pfizer, Egypt; Pfizer, Ghana; Pfizer, Kenya; Pfizer, Liberia; Pfizer, Malawi; Pfizer, Nigeria; Pfizer, Sudan; Pfizer, Sierra Leone



• Metastamin
  Maruishi, Japan



• Spiegel
  Fuso Pharmaceutical, Japan

International Drug Name Search

Glossary

IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Prop.INN	Proposed International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.